Filtered By:
Condition: Heart Attack
Nutrition: Vitamins

This page shows you your search results in order of relevance. This is page number 17.

Order by Relevance | Date

Total 592 results found since Jan 2013.

The Role of Vitamin Supplementation in the Prevention of Cardiovascular Disease Events
ABSTRACT The production, sale, and consumption of multiple vitamins is a multibillion‐dollar industry. Most Americans take some form of supplement ostensibly for prevention of cardiovascular disease. It has been claimed that vitamin A retards atherogenesis. Vitamin C is an antioxidant and is thought to possibly decrease free radical‐induced endothelial injury, which can lead to atherosclerotic plaque formation. Vitamin E has been extensively studied for its possible effects on platelet function as well as inhibition of foam‐cell formation. Low levels of vitamin D have been thought to negatively impact myocardial stru...
Source: Clinical Cardiology - April 1, 2014 Category: Cardiology Authors: Chirag K. Desai, Jennifer Huang, Adil Lokhandwala, Aaron Fernandez, Irbaz Bin Riaz, Joseph S. Alpert Tags: Review Source Type: research

Vitamin D Deficiency and Cardiovascular Events in Patients With Coronary Heart Disease: Data From the Heart and Soul Study
A growing body of evidence supports an association between vitamin D and cardiovascular disease. However, the mechanisms underlying this association are unknown. From 2000 to 2002, we identified 946 participants with stable cardiovascular disease in San Francisco, California, and followed them prospectively for cardiovascular events (heart failure, myocardial infarction, stroke, or cardiovascular death). We then examined the extent to which the association was attenuated by adjustment for poor health behaviors, comorbid health conditions, and potential biological mediators. During a median follow-up period of 8.0 years (th...
Source: American Journal of Epidemiology - May 27, 2014 Category: Epidemiology Authors: Welles, C. C., Whooley, M. A., Karumanchi, S. A., Hod, T., Thadhani, R., Berg, A. H., Ix, J. H., Mukamal, K. J. Tags: RESEARCH-ARTICLE Source Type: research

The ‘Dual‐Pathway’ Strategy After Acute Coronary Syndrome: Rivaroxaban and Anti‐platelet Agents in the ATLAS ACS 2‐TIMI 51 Trial
This article is protected by copyright. All rights reserved.
Source: Cardiovascular Therapeutics - June 1, 2014 Category: Cardiology Authors: Marc Cohen, Deepa Iyer Tags: Unsolicited Review Source Type: research

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy
This report describes the intent-to-treat comparison of the 4 factorial groups overall and in patients with diabetes.Methods: This was a double-blind, placebo-controlled, 2 × 2 factorial multicenter randomized trial of 1,708 post–myocardial infarction (MI) patients ≥50 years of age and with creatinine ≤2.0 mg/dL randomized to receive 40 EDTA chelation or placebo infusions plus 6 caplets daily of a 28-component multivitamin-multimineral mixture or placebo. The primary end point was a composite of total mortality, MI, stroke, coronary revascularization, or hospitalization for angina.Results: Median age was 65 years, 1...
Source: American Heart Journal - April 4, 2014 Category: Cardiology Authors: Gervasio A. Lamas, Robin Boineau, Christine Goertz, Daniel B. Mark, Yves Rosenberg, Mario Stylianou, Theodore Rozema, Richard L. Nahin, L. Terry Chappell, Lauren Lindblad, Eldrin F. Lewis, Jeanne Drisko, Kerry L. Lee Tags: Coronary Artery Disease Source Type: research

Aspirin Therapy in Primary Cardiovascular Disease Prevention A Position Paper of the European Society of Cardiology Working Group on Thrombosis
Although the use of oral anticoagulants (vitamin K antagonists) has been abandoned in primary cardiovascular prevention due to lack of a favorable benefit-to-risk ratio, the indications for aspirin use in this setting continue to be a source of major debate, with major international guidelines providing conflicting recommendations. Here, we review the evidence in favor and against aspirin therapy in primary prevention based on the evidence accumulated so far, including recent data linking aspirin with cancer protection. While awaiting the results of several ongoing studies, we argue for a pragmatic approach to using low-do...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - July 14, 2014 Category: Cardiology Source Type: research

Prevalence of Vitamin D Deficiency Prior to Cardiothoracic Surgery
Vitamin D deficiency is one of the most common chronic medical conditions in the world and also prevalent in Australia. A growing body of evidence suggests that low vitamin D also has adverse effects on cardiovascular health, including coronary risk factors and adverse cardiovascular outcomes such as myocardial infarction, cardiac failure and stroke.There is some evidence suggesting that a greater proportion of people with cardiovascular disease have low vitamin D compared to the general population.
Source: Heart, Lung and Circulation - July 1, 2014 Category: Cardiology Authors: Lesley A. Braun, Ondine Spitzer, Bianca Levkovich, Michael Bailey, Cathy Stanguts, Lisa Hose, Franklin Rosenfeldt Source Type: research

Aspirin-Responsive, Migraine-Like Transient Cerebral and Ocular Ischemic Attacks and Erythromelalgia in JAK2-Positive Essential Thrombocythemia and Polycythemia Vera.
Abstract Migraine-like cerebral transient ischemic attacks (MIAs) and ocular ischemic manifestations were the main presenting features in 10 JAK2(V617F)-positive patients studied, with essential thrombocythemia (ET) in 6 and polycythemia vera (PV) in 4. Symptoms varied and included cerebral ischemic attacks, mental concentration disturbances followed by throbbing headaches, nausea, vomiting, syncope or even seizures. MIAs were frequently preceded or followed by ocular ischemic events of blurred vision, scotomas, transient flashing of the eyes, and sudden transient partial blindness preceded or followed erythromela...
Source: Acta Haematologica - August 7, 2014 Category: Hematology Authors: Michiels JJ, Berneman Z, Gadisseur A, Lam KH, De Raeve H, Schroyens W Tags: Acta Haematol Source Type: research

Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.
CONCLUSION: We failed to show an association between vitamin D, apelin and MPV higher volumes of which may have a role in cardiovascular complications related to diabetes by increasing platelet activation. PMID: 25156130 [PubMed - as supplied by publisher]
Source: Annales d'Endocrinologie - August 22, 2014 Category: Endocrinology Authors: Kiskac M, Zorlu M, Cakirca M, Karatoprak C, Kesgin S, Büyükaydın B, Yavuz E, Ardic C, Camli AA, Cikrikcioglu MA Tags: Ann Endocrinol (Paris) Source Type: research

Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease.
Abstract Endothelial nitric oxide synthase (eNOS or NOS3), an enzyme constitutively expressed especially in endothelial cells, is largely responsible for nitric oxide (NO) bioavailability at the endothelial level. Alterations in endothelial-derived NO production have been associated with various diseases, and, in humans, can be genetically determined by the presence of different polymorphisms in the eNOS gene. To date, the most studied and functionally related polymorphisms are: Glu298Asp (rs1799983), -786T/C (rs2070744), and the intron 4 variable number tandem repeat. Evidence supports a major role of these varia...
Source: Vitamins and Hormones - September 9, 2014 Category: Endocrinology Authors: Vecoli C Tags: Vitam Horm Source Type: research

The “Dual‐Pathway” Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2‐TIMI 51 Trial
Summary Acute coronary syndrome (ACS) is a medical emergency often associated with an occlusive coronary event with consequent myocardial underperfusion. Patients require immediate antiplatelet therapy and long‐term antithrombotic prophylaxis to reduce the risk of recurrence. Acetylsalicylic acid (ASA) alone or in combination with a platelet P2Y12 inhibitor (dual antiplatelet therapy [DAPT]) has become the clinically accepted antithrombotic prophylaxis for patients post‐ACS. Historically, studies assessing the utility of adding oral anticoagulants (OACs) have not demonstrated a clinical benefit with regard to acceptabl...
Source: Cardiovascular Therapeutics - September 9, 2014 Category: Cardiology Authors: Marc Cohen, Deepa Iyer Tags: Review Source Type: research

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease
BackgroundAlthough there is evidence that patients who experience major bleeding after an acute coronary event are at higher risk of death in the months after the event, the incidence and impact on outcome of bleeding beyond 1 year of follow-up in patients with stable coronary artery disease (CAD) are largely unknown.ObjectivesThe goal of this study was to assess the incidence, source, determinants, and prognostic impact of major bleeding in stable CAD.MethodsWe prospectively included 4,184 consecutive CAD outpatients who were free from any myocardial infarction (MI) or coronary revascularization for>1 year at inclusion. F...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - September 29, 2014 Category: Cardiology Source Type: research

Fruit juice link to high blood pressure not proven
ConclusionThis cross-sectional study found a link between regular fruit juice consumption and slightly increased central blood pressure in a group of 130 largely healthy 50 to 70 year olds. People who drank juice daily had a systolic pressure (the upper figure) 3 to 4mmHg higher than those who drank juice rarely or occasionally.However, when measuring the blood pressure in the standard way, using an inflatable cuff around the arm, there was no link.  The media reports focus on the possibility that the slight raise in blood pressure could increase a person's risk of a variety of blood pressure-related complications. But it...
Source: NHS News Feed - October 13, 2014 Category: Consumer Health News Tags: Heart/lungs Food/diet Source Type: news

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy
Conclusions In stable post-MI patients on evidence-based medical therapy, the combination of oral high-dose vitamins and chelation therapy compared with double placebo reduced clinically important cardiovascular events to an extent that was both statistically significant and of potential clinical relevance.
Source: American Heart Journal - October 20, 2014 Category: Cardiology Source Type: research

Prevalence of Vitamin D Deficiency Prior to Cardiothoracic Surgery
Vitamin D deficiency is one of the most common chronic medical conditions in the world and also prevalent in Australia. A growing body of evidence suggests that low vitamin D also has adverse effects on cardiovascular health, including coronary risk factors and adverse cardiovascular outcomes such as myocardial infarction, cardiac failure and stroke.There is some evidence suggesting that a greater proportion of people with cardiovascular disease have low vitamin D compared to the general population.
Source: Heart, Lung and Circulation - July 1, 2014 Category: Cardiology Authors: Lesley A. Braun, Ondine Spitzer, Bianca Levkovich, Michael Bailey, Cathy Stanguts, Lisa Hose, Franklin Rosenfeldt Tags: Brief Communication Source Type: research

Management of venous thrombo-embolism: an update
Venous thrombo-embolism is the third most frequent acute cardiovascular syndrome after myocardial infarction and stroke. Recently published landmark trials paved the way for significant progress in the management of the disease and provided the evidence for the ESC Pulmonary Embolism (PE) Guidelines 2014 update. Risk stratification strategies for non-high-risk PE continue to evolve, with an increasing emphasis on clinical prediction rules and right ventricular (RV) assessment on computed tomographic pulmonary angiography. In the field of anticoagulation treatment, pharmacogenetic testing for vitamin K antagonists on top of...
Source: European Heart Journal - November 1, 2014 Category: Cardiology Authors: Konstantinides, S., Torbicki, A. Tags: Frontiers in cardiovascular medicine Source Type: research